1. Home
  2. SPNS vs EVO Comparison

SPNS vs EVO Comparison

Compare SPNS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPNS
  • EVO
  • Stock Information
  • Founded
  • SPNS 1982
  • EVO 1993
  • Country
  • SPNS Israel
  • EVO Germany
  • Employees
  • SPNS N/A
  • EVO N/A
  • Industry
  • SPNS Computer Software: Prepackaged Software
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPNS Technology
  • EVO Health Care
  • Exchange
  • SPNS Nasdaq
  • EVO Nasdaq
  • Market Cap
  • SPNS 1.5B
  • EVO 1.5B
  • IPO Year
  • SPNS 1992
  • EVO 2021
  • Fundamental
  • Price
  • SPNS $28.39
  • EVO $4.30
  • Analyst Decision
  • SPNS Buy
  • EVO Buy
  • Analyst Count
  • SPNS 4
  • EVO 2
  • Target Price
  • SPNS $34.25
  • EVO $5.90
  • AVG Volume (30 Days)
  • SPNS 185.0K
  • EVO 152.8K
  • Earning Date
  • SPNS 05-08-2025
  • EVO 05-06-2025
  • Dividend Yield
  • SPNS 3.40%
  • EVO N/A
  • EPS Growth
  • SPNS 11.11
  • EVO N/A
  • EPS
  • SPNS 1.30
  • EVO N/A
  • Revenue
  • SPNS $544,235,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • SPNS $4.49
  • EVO $11.29
  • Revenue Next Year
  • SPNS $5.15
  • EVO $13.20
  • P/E Ratio
  • SPNS $21.79
  • EVO N/A
  • Revenue Growth
  • SPNS 3.84
  • EVO 1.50
  • 52 Week Low
  • SPNS $23.69
  • EVO $2.84
  • 52 Week High
  • SPNS $41.22
  • EVO $5.68
  • Technical
  • Relative Strength Index (RSI)
  • SPNS 58.57
  • EVO 61.35
  • Support Level
  • SPNS $27.47
  • EVO $3.91
  • Resistance Level
  • SPNS $29.90
  • EVO $4.38
  • Average True Range (ATR)
  • SPNS 0.79
  • EVO 0.13
  • MACD
  • SPNS 0.18
  • EVO 0.01
  • Stochastic Oscillator
  • SPNS 63.35
  • EVO 86.89

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: